throbber

`
`
`TFS1018
`
` Tse
`ecembertSaco
`x
`“a
`
`
`a pet 22 ee! aa
`
`ublished by the American Physiologica?Society
`
`
`1
`
`1
`
`TFS1018
`
`

`

`Physiological Genomics
`
`Editor-in-Chief: V. DZAU
`
`Deputy Editor: M. J. FINLEY AUSTIN
`
`Senior Editors:
`R. AEBERSOLD
`P.O. BROWN
`
`Associate Editors:
`W.AIRD
`S.ALPER
`P.ANDREWS
`J . DERISI
`
`Editorial Board:
`H. ABURATANI
`M.ALTHERR
`F. BAAS
`\V. BERRETTINI
`\V. BORON
`C. A. R. BOYD
`D. BROOK
`H. BUSSEY
`C. T. CASKEY
`K R. CHIEN
`G. CHURCH
`P. CORVOL
`A. DOIV!INICZAK
`S. FIELDS
`lVI. FISHl\'lAN
`
`A. W. COWLEY, JR.
`D. HOUSMAN
`
`R. !VIULLIGAN
`R. ROSENBERG
`
`M. EISEN
`S.GULLANS
`H. JACOB
`A. J. LINK
`
`J. PELLETIER
`R. PRATT
`L.STAUDT
`L.ZON
`
`J. FRIEDl\·lAN
`A. FUKAM IZU
`D.GANTEN
`W. GUGGINO
`J. HALL
`S. HARRAP
`J. R. HAYWOOD
`I. HUMPHERY-SMITH
`S. JZUMO
`J. KRIEGER
`J.KUNES
`T.KURTZ
`E.S.LAN DER
`B. LEFKOWITZ
`H. LEHRACH
`
`H. LESTER
`H. LEWIN
`M.LOVETT
`H. MCDEVITT
`R. JVJCJNNES
`J. MULLENS
`M.PRINTZ
`J. RAPP
`R.ROMAN
`A. RUT
`L. SAMUELSON
`J. SANES
`C.SAPER
`J.SASSARD
`C. SIGl\'IUND
`
`S. SNYDER
`M. BENTO SOARES
`G. STAJ\JATOYANNOPOULOS
`M. STOLL
`I<. STRANGE
`J. TAKAI-IASI-11
`R. TANZ I
`S.TONEGAWA
`L.-C. TSUI
`T. UNGER
`H. WE ILER
`M.J. WELSH
`M. WHITE
`B. ZABEL
`
`Publications Committee
`D. J. BENOS , Chair
`D.H.ALPERS
`R. D. l\1.ANNING, JR.
`J. A. SCHAFER
`S. H. WRIGHT
`
`Ex officio
`M.REICH
`Publication s Manager
`and Executive Editor
`W. F. BORON, President
`M. FRANK, Executive Director
`
`A. G. TRUDGETT
`Editorial Manager
`Z. ERIM
`M. GOODWIN
`Senior Copy Edt.tors
`
`Physiologica l Genomics (ISSN-
`1094-8341) is published by the
`American Physiological Society,
`9650 Rockville Pike, Bethesda, MD
`20814-3991. Subscription Prices:
`Institutional: $200.00, US; $215.00,
`Canada a nd Mexico; $230.00, else(cid:173)
`where. Non-member individua l:
`$133.00, US; $150.00, Canada and
`Mexico; $165.00, elsewhere. APS
`member: $65.00. S ubscriptions
`from outside the United States are
`payable in US currency or full
`equivalent . J apanese yen price is
`available from om agent: USACO
`
`Corporation, 13-12 Shimbashi 1-
`Chome, Minato-Ku, Tokyo 105, J a(cid:173)
`pan. Subscriptions are accepted on
`a calendar-year basis only. S ingle
`Copies and Bach Issues: When
`availa ble, $50.00 each postpaid.
`
`Copyri ght © 1999 by the American
`Physiological Society. Printed in
`the United States of America . The
`code at the bottom of the first page
`of an a rticle indi cates the copy(cid:173)
`right owner's consent that copies
`of that article may be made be(cid:173)
`yond that permitted by sections
`
`107 and 108 of the US Copyright
`Law-unless the copies a re for gen(cid:173)
`eral distribution, for advertising,
`for creating new works, or for re(cid:173)
`sale-provided the per-copy fee is
`paid through the Copyright Clear(cid:173)
`a nce Center, Inc., 222 Rosewood
`Dr., Danvers, M.A. 01923 . 1094-
`8341/99 $5 .00.
`
`Editorial and Business Correspon(cid:173)
`de nce: Physiological Genomics,
`9650 Rockville Pike, Bethesda, MD
`20814-3991. E-mail : www.physiol(cid:173)
`genomics.org
`
`2
`
`

`

`Physiological Genomics
`MANDATORY SUBMISSION FORM
`
`Title:
`
`oResearch Artic le o BriefCommunication o Perspecti ve o News and Reports o Ed itorial o Lette r to Edi tor o Review o Too lbox
`
`A Signature Below Certifies Complian ce W ith th e Following Statem ents
`Copyright T ra ns fer. In consideration of th e acceptance of th e above wo rk for publication, I do hereby ass ign and transfer to The
`American Physio log ical Society all rights, title, and interest in and to th e copyright in the above-titled work. If any changes in
`authorsh ip (order, deletion s, or addition s) occur after the manuscript is submitted, agreement by all authors for such changes must be
`on file with the Soc iety . An author's name may only be removed at his/her own request. (Note: material prepared by empl oyees of the
`u.s. govern me nt in th e course of their offici al duties cannot be copyrighted.)
`*For com mercial companies authorized agent signatures are allowed for copyright transfer but authors must sign fo r authorshi p
`responsib ilities.
`Aut horship Res ponsibilities to be signed by each author
`Each autho r is required to attest that the manuscript is not currentl y under consideration elsewhere and the research reported will not be submi tted for
`publication elsewhere until a fi nal decision has been made as to its acceptability by the journal;
`the manuscript is truthful original wo rk without fa brication, fra ud, or plagiarism; each author has made an important scientific contri bution to the
`study and is tho roughly fa mili ar with the primary data; and each author has read the complete manuscript and takes responsibility fo r the content and
`completeness of the manuscript and understands that if the paper or part of the paper is foun d to be faul ty or fraudulent, he or she shares the
`responsibi lity. If the paper depends critically on another paper that is as yet unpubli shed, three copies of that paper should be included fo r reviewers.
`In cases in which obtaining a signature from each author would delay rev iew, the corresponding author's signature is suffic ient prov ided that the
`correspond ing author understands that he or she signs on behalf of all of the authors who have not signed the fo rm . It should also be un derstood by
`all authors that the corresponding author has signed th e manuscript submission fo rm as their proxy.
`Conflict of Inter est D isclosu re. A ll funding sources supporting the work and all in sti tutional or corporate affi liations of min e are
`acknowledged. Except as di sclosed on a separate attachment, I certi fy th at I have no commercia l assoc iati ons (e.g. , consultancies, stock
`ownership, equi ty interests, patent-li censing arrangements) th at might pose a conflict of interest in connection w ith the submitted
`article (letter attached).
`
`0 Please check if this article was written as part of the officia l duties of an employee of the U. S. G ove rnm ent
`
`Sign ature from EACH author required in th e sam e order a s on the manuscript ti t le page (Fax Signatures, Multi ple Forms
`Acceptab le). For more than 7 authors, use an extra sheet.
`
`Signature
`
`Signature
`
`Print Name
`
`Print Name
`
`Date
`
`Date
`
`Signatu re
`Date
`Print Name
`------------------------------------------------------------------------------------------------------
`Signature
`Print Name
`Date
`-----------------------------------------------------------------------------------------------------
`Signature
`Print Name
`Date
`
`Date
`Signature
`Print Na me
`---------------------------------------------------------------------------------------
`Signature
`Print Name
`Date
`
`'Commercial company agent's signature (if applicable)----------------------------------------------------------------------
`
`Co rresponding Author
`
`Phone --------------------- I' ax
`
`Mailing Address -----------------------------------------------------------------------------------------------
`
`--------------------------------------------------------------- E-mail ------------------------------------
`
`Please fax to 301 -571 -1814
`
`3
`
`

`

`.if
`
`~-
`
`WhY FRET over genomics?
`
`review
`
`DINO A. DE ANGELIS
`Cellular B iochem istry and Biophysics Program, Memoria l Sloan-Kettering
`Cancer Cente1; N ew York, N ew Yorll 10021
`
`DeAngelis, Dino A. Why FRET over genomics? Physiol. Genomics 1:
`93-99, 1999.-Gen etic information is being uncover ed quickly and in
`vast amounts through the largely a utomated sequencing of genomes from
`all kinds of organisms. As this information becomes available, enormous
`ch allenges a re emerging on three levels: first, functions will h ave to be
`assigned to individual gen e products; second, factors that influen ce the
`expression level of these gene products will h ave to be identified; and
`third, allelic variants th at act alone or in combination to give rise to
`complex traits will have to be ch ar acterized. Because of th e sh eer size of
`genomes, methods that can streamline or a utomate th ese processes are
`highly desirable. Fluorescence is an attractive readout for such high(cid:173)
`throughput tasks because of th e availability of equipment designed to
`detect light-emitting compounds with great speed and high capacity. The
`following is a n overview of th e achievemen ts and potential of fluorescence
`resonance energy tra nsfer (FRET) as applied in three areas of genomics:
`t he identification of single-nucleotide poly.morphisms, th e detection of
`protein-protein interactions, a nd th e genomewide analysis of regulatory
`sequences.
`green fluorescent protein; proximity imaging; high-throughput screen(cid:173)
`ing; single-nucleotide polymor phism; fluorescence-activated cell sor ting;
`digital imaging spectr oscopy
`
`FLUORESCENCE RESONANCE ENERGY TRANSFER
`
`Fluorescence r esonance en ergy transfer (FRET) is a
`quantum m echanical phenomenon that occurs between
`a fluorescence donor (D ) and a fluorescence acceptor (A)
`in close pr oximity (usually < 100 A of separ ation) if th e
`emission spectrum of D overlaps with th e excitation
`spectrum of A (Fig. 1A) (15). Under optimal FRET
`conditions, illumination at the excitation wavelength of
`D results in tra nsfer of ener gy, not photons, to A. If A is
`nonfluor escent, it can be r eferred to as a quencher (Q );
`in this case, FRET between D and Q r esults in a n et
`decrease in photon emission from D (Fig. 1C) . If A is
`also fluorescent, the decrease in emission from D is
`concomitant with an increase in fluorescence at the
`emission wavelen gth of A (Fig. 1B). The efficien cy of
`energy transfer (E ) decreases very rapidly with increas(cid:173)
`ing distance (R ) between the donor and acceptor, accord(cid:173)
`ing to th e r elationship E rx [1 + (RIR0 )6]- l, wh er e R 0 is
`the distance at which E is 50%. To illustr a te this point,
`simply making R = 2 X R 0 decreases FRET effici ency
`from 50% to ~ 1%.
`
`Received 3 June 1999; accepted in fi nal form 29 J~1ly 1999.
`Ar ticle published online before print . See web site fo r date of
`Publication (http://physiolgenomics.physiplogy.org).
`
`FRET-induced ch a n ges in fluorescence intensity
`(wh en A is a nonfluorescent quen ch er, Q) or in th e r atio
`of emission inten sities of th e donor and acceptor (wh en
`A is fluorescen t) h ave been widely exploited in biology
`to monitor proximity relationships between appropri(cid:173)
`ately labeled m acromolecules (3 1, 33). Absolute dis(cid:173)
`t ances between donor and acceptor pair s can be mea(cid:173)
`sured with FRET; it h as been coined a "spectroscopic
`r uler" (33). However, absolute distance measurements
`ar e not u su ally a ttempted becau se F RET efficiency is
`also influenced by th e angle between the dipole mo(cid:173)
`ments of D a nd A, a par a meter th a t is often difficult t o
`qu an tify. Th e most common application of th e tech (cid:173)
`nique is to dyn a mically monitor th e r elative distance
`between D and A aft er chan ges induced in the system
`under study.
`
`ANALYSIS OF SINGLE-NUCLEOTIDE POLYMORPillSMS
`WITH FRET
`
`One of th e greatest ch allenges facing geneticists is
`th e analysis of complex traits and diseases. Complexity
`arises because ther e is no simple correspondence be(cid:173)
`tween genotype and phenotype, for instance, when
`muta tions in a ny one of several genes r esult in the
`sam e phenotype or wh en mutations in several genes
`ar e r equired to give rise to a particular trait (20) . One
`way of zeroing in on candidate gen es is through gen etic
`
`1094-8341199· $5.00 Copyright © 1999 the Am erican Physiological Society
`
`93
`
`4
`
`

`

`94
`
`REVIEW
`
`A
`
`Fig. 1. Fluorescence resonance en ergy tra nsfer (FRET).
`A: excitation (dotted lines) and emission (solid lines)
`spectra of a n ideali zed fluorescence donor (D, white
`lines) and fluorescence acceptor (A, black lines) pair.
`Parti a l overlap between emission spectrum of D and
`excitation spectrum A is shown in shaded ar ea. Wave(cid:173)
`length a nd inten sity va lues ar e in arbitrary units . B:
`schematic representation of a fluorescence donor (D)
`and acceptor (A) pair. B, left: D and A are not wit hin
`FRET distance; excitation ofD res ults in emission from
`D. B, rig ht: D and A are within FRET dista nce; excita (cid:173)
`tion of D results in tran sfer of energy to A (white
`lightning), ca using net increase in a mount of light
`emitted fTom A concomitant with decrease in amount of
`light emitted from D. C: same as in B, but acceptor is a
`nonfluorescent quencher (Q); energy transfer (white
`lightning) res ults in net decrease in fluorescence inten(cid:173)
`sity of D.
`
`B
`
`wavelength
`
`c
`
`association studies that compare the prevalence of a
`marker (or a set of markers) between affected and
`nonaffected individuals. Single-nucleotide polymor(cid:173)
`phisms (SNPs) are genetic markers that are densely
`distributed throughout the genome, at an average
`frequency of 1 per 1,000 base pairs (8). Organizations
`such as the National Human Genome Research Insti(cid:173)
`tute (http://www.nhgri.nih.gov/) and the recently
`created SNP Consortium (23) are creating public data(cid:173)
`bases cataloguing several hundreds of thousands of
`these markers. These databases, coupled with efficient
`methodologies to detect SNPs, will facilitate the identi(cid:173)
`fication of genes responsible for complex disorders such
`as diabetes, hypertension, or schizophrenia.
`Although SNPs can be successfully analyzed by
`traditional methods based on gel separation (Sanger or
`Maxam-Gilbert sequencing, restriction fragment length
`polymorphism), several more efficient/automatable al(cid:173)
`ternatives have been devised (19) . Most methods are
`based on differences in hybridization to a given oligo(cid:173)
`nucleotide probe between a perfectly matched and a
`mismatched sequence. For instance, DNA chips consist
`of thousands of oligonucleotide probes arrayed at high
`density on a solid support in a predetermined order
`(37). DNA samples are amplified by PCR using fluores(cid:173)
`cent nucleotide analogs; these labeled PCR products
`can only hybridize to perfectly matching oligonucleo(cid:173)
`tide sequences immobilized on tli.e .chip. Images of the
`hybridized fluorescent probes are obtained by confocal
`microscopy of the chip, allowing direct comparison
`
`between patient and control hybridization patterm
`The main advantage ofthis approach is that it enabl
`the simultaneous detection of thousands of SNPs fro
`a given genomic DNA sample; however, the fact tha
`the probes are fixed to a chip that is difficult
`manufacture hinders the detection of newly cataloguec
`SNPs.
`More flexibility is provided by simple homogeneoll!
`assays that allow the detection ofSNPs in solution; fow
`of these are based on FRET and have been reviewed iD
`detail elsewhere (19). The TaqMan assay (21) is
`protocol that utilizes short oligonucleot ides probes tha
`undergo FRET in their intact state because they an
`labeled at each end with a fluorescence donor a
`acceptor pair (Fig. 2A ). Even in probes longer than 3(
`nucleotides, significant FRET can occur because
`hydrophobic interactions between D and A (5). Tbl
`probe is designed to hybridize to a sequence be·
`amplified in a PCR reaction using Taq polymeraJ
`(downstream of one of the primers). If there is a perfl
`match between the probe and the target, the 5
`exonuclease activity of Taq polymerase can digest tbl
`hybridized TaqMan probe during the elongation cycle
`separating D from A and resulting in a decrease ·
`FRET.
`The "molecular beacons" of 'I'yagi and Kramer (36
`represent a second approach. These oligonucleotidi
`probes are chemically modified with a fluore scen
`donor (EDANS) at their 5' end and a nonfluorescenl
`quenching acceptor (DABCYL) at their 3' end. In
`
`http://physiolgenomics.physiology.org
`
`5
`
`

`

`MISMATCH
`
`A
`
`B 0
`
`X
`
`c
`
`D
`
`REVIEW
`
`MATCH
`
`95
`
`Fig. 2. Four FRET-based approaches for
`analysis of single-nucleotide polymor(cid:173)
`phisms (SNPs) in solution. A: Taql\•Ian
`assay. A , left : TaqMa n probe does not
`match ta rget DNA (gray horizontal li ne;
`mismatch represented by ''X") a nd under(cid:173)
`goes FRET in the intact state upon illumi(cid:173)
`nation of D; 7hq polym erase (Taq) ca n
`extend a PCR primer (arrow ) loca ted up(cid:173)
`stream of mismatched target sequence. A,
`.right: hybridized TaqMa n probe is di(cid:173)
`gested by 5'-exonuclease activity of Taq
`polymerase duri ng exte nsion of PCR
`primer, resul ting in separation of D from
`A a nd disruption of FRET signa l. B: mo(cid:173)
`lecular beacons. B , left : in presence of a
`mismatched target , the probe adopts a
`s tem-and-loop s tructure; because of prox(cid:173)
`imity of 5' a nd 3' ends of probe, donor (D)
`fl uorescence is di rectly coupled to nonfluo(cid:173)
`rescent quenching acceptor (Q ), resulting
`in very low levels of fl uor escence emission
`from D. B, rig ht : in presence of correct
`target , molecular beacon h ybridizes per(cid:173)
`fectly to the ta rget ; D and Q are sepa(cid:173)
`rated, giving rise to a disruption of FRET
`a nd a n increase in em ission from D. C:
`dye-labeled oligonucleotide ligation (DOL).
`C, left : a mismatch at junction between 2
`contiguous oligonucleotides [one labeled
`with a fluorescence donor (D) and t he
`other with an acceptor (A)) prevents DNA
`ligase (Lig) from joini ng the 2 fragments
`together, preventing energy transfer be(cid:173)
`tween D and A. C, rig ht : a perfect match
`allows ligase to li nk the oligonucleoticles,
`resulting in FRET. D: template-directed
`dye-terminator incorpora tion (TDI). DNA
`polymer ase (Pol) a nd an a cceptor-labeled
`n ucleotide ter minator analog correspond(cid:173)
`ing to SNP of interest a re added to a
`fl uorescence donor-labeled oligonucleo(cid:173)
`tide hybridized to a DNA ta rget . D, left: in
`a misma tch situation, the analog is not
`incorpor ated at the 3' end of the primer
`and FRET does not occur. D, rig ht : with a
`perfect ma tch, the ana log is incor pora ted
`a nd FRET resul ts.
`
`absence of a perfectly m at ch ed target , they assume a
`stem-and-loop structure in solution: the loop is a DNA
`strand complem entary to th e tar get, and th e st em is
`formed by intr amolecular base-pair ing of short comple(cid:173)
`ment ary sequences at each end of th e loop (Fig. 2B ).
`This hairpin conformation positions D and Q in ex(cid:173)
`tremely close pr oximity, much closer th a n a pair of
`fluorophores at opposite ends of a r andomly coiled
`oligonucleotide; this effectively quen ch es donor fluores(cid:173)
`cence . In the presen ce of a perfectly m atch ed sequence,
`the oligonucleotide under goes a confor mational ch ange
`that allows the h airpin loop to hybridize to the t ar get ,
`separating D from Q a n d r esulting in a fluor escen ce
`increase (up to 900-fold; Fig. 2B). Th e ability of molecu (cid:173)
`lar beacons to form h air pin structures sig11ificantly
`enhances their specificity compar ed with st andard
`oligonucleotide pr obes of th e same size, allowing th em
`to readily distinguish between a perfect m at ch and a
`single base mism atch (3) . Recently, molecular beacons
`With seven additional donors r anging from blue to r ed
`fluor escence emission have been developed , permitting
`
`th e simulta n eous detection of several target s within
`the sam e tube (35).
`Dye-labeled oligonucleotide ligation (DOL) (7) is a
`third FRET-based technique th at relies on th e extreme
`sensitivity of DNA ligase to mism atch es close t o th e
`ligation site. Th e m ethod ut ilizes two oligonucleotides,
`one labeled with a fluorescen ce donor, th e oth er with an
`acceptor (Fig. 2C) . The probes are designed to hybridize
`adjacen tly on a cont iguous DNA target sequence; if
`both oligonucleotides m atch perfectly, DNA ligase can
`join th e fragm ents togeth er, resulting in FRET. A
`mism at ch locat ed on the 3' end of the ligation site (first
`base of th e oligonucleotide) will r esult in failure of th e
`ligase t o link th e labeled oligonucleotides, thus preven t(cid:173)
`ing FRET.
`Fin ally, in templa t e-direct ed dye-t erminator incorpo(cid:173)
`r ation (TDI) (6), a donor-labeled oligonucleotide primer
`designed with its 3' end immedia tely adj acent to a
`polymor phic nucleotide is allowed to hybridize to a
`given tar get sequ ence (Fig. 2D ). In a subsequent reac(cid:173)
`tion simila r to dideoxy chain t ermination sequencing,
`
`http://physiolgenomics.physiology.org
`
`6
`
`

`

`96
`
`REVIEW
`
`DNA polymerase and an acceptor-labeled nucleotide
`terminator analog corresponding to the SNP of interest
`are added; FRET results only if the analog is incorpo(cid:173)
`rated at the 3' end of the primer, indicating a perfect
`match. Although TDI is extremely easy to optimize, it
`necessitates addition of specific reagents twice after the
`initial reaction setup; the other three FRET-based
`methods are "walk-away" assays that only require
`proper thermal cycling ofthe initial reaction mixture.
`Although these four methods do not approach the
`degree of parallelism or multiplexing offered by high(cid:173)
`density DNA arrays, where simultaneous analysis of
`thousands of SNPs per reaction is customary, they are
`much more flexible: new SNPs can be detected without
`having to remanufacture a custom DNA chip because
`the specific probes and reagents required are easy to
`obtain or synthesize. Moreover, these FRET-based as(cid:173)
`says are fast and simple: with the exception ofTDI (see
`above), all necessary reagents are initially combined
`and changes in FRET can be monitored in real time
`during the course of the assays without having to
`process the samples further and without the help of
`expensive imaging equipment.
`
`ANALYSIS OF CODING SEQUENCES: PROTEIN-PROTEIN
`INTERACTIONS ANALYZED WITH FRET AND PRIM
`
`Because most cellular processes are carried via pro(cid:173)
`tein assemblies, important clues to the function of a
`novel gene product can be obtained by identifYing the
`set of proteins with which it interacts. On a genome(cid:173)
`wide basis, such information would constitute what has
`been termed "protein linkage maps" (13) . Methods able
`to streamline the identification of protein-protein inter(cid:173)
`actions are necessary to cope with the large amount of
`genomic data being generated (4). In the yeast two(cid:173)
`hybrid system (14), the DNA binding domain of a
`transcription factor is fused to a sequence of interest in
`a vector, and a DNA library is fused to the transcrip(cid:173)
`tional activation domain in a second vector. Protein(cid:173)
`protein interactions are detected in cotransformed yeast
`colonies on the basis of reconstituted transcriptional
`activity, which is coupled to a functional effect (usually
`survival on selective media). Inserting a library in each
`of the vectors allows the mapping of protein-protein
`interactions on a genomewide basis, as was demon(cid:173)
`strated with the bacteriophage T7 genome (2); larger
`genomes can be handled with multiple-round two(cid:173)
`hybrid screens (16). In phage-display technologies,
`eDNA libraries are expressed on the surface of phage
`particles directly through fusion to a coat protein (18)
`or indirectly via strong noncovalent interaction with a
`modified coat protein (10). Typically, the phage libraries
`are presented to a target immobilized on a solid sup(cid:173)
`port; nonbinding phages are washed away and specific
`binding phages are enriched and analyzed (27). A
`combination of phage and bacterial display has re(cid:173)
`cently been developed that can potentially detect inter(cid:173)
`actions not only between a target protein and a library
`of coding sequences but also between two libraries (4, 22).
`Since the initial cloning of green fluorescent protein
`from the jellyfish Aequorea vic~oria and its expression
`
`in differ ent cells and organisms . (5, 30), the codin
`sequence h as been mutagenized extensively t o improv
`or alter some of the spectral and biophysical propertie
`ofthe original. The various mutants have recently bee
`grouped under seven classes (34), including varian ·
`emitting light of different wavelengths: green, hlu~
`cyan, and yellow fluorescent proteins (GFP, BFP, CFI:
`and YFP, respectively). The advent of these spectra
`variants has opened up another platform for the detet.
`tion of protein-protein interactions: appropriately se.
`lected mutants can serve as D-A pairs in a FRET
`scheme. In proof-of-concept experiments (17, 25), BFp
`(D) and GFP (A) were linked together via spacers of2o
`or 25 amino acids containing a protease cleavage site
`As a result afforced proximity, substantial intramolecu.
`lar energy transfer occurred from BFP to GFP in th
`uncleaved species; addition of the specific protease l
`to the disappearance of the FRET signal. GFP donors
`and acceptors have since been used in numerous FRET
`based applications (29). Currently, the optimal D-A pair
`consists of optimized CFP and YFP variants, respec
`tively (26). The drawbacks ofusing a 28-kDa protein a:
`a fluorescent tag (large size, possible disruption o
`protein function) are outweighed by the advantages o
`specifically and homogeneously labeling a given protein
`and targeting it to any subcellular location for which
`there is a known consensus sequence.
`The ease with which given coding sequences can be
`fused to GFP suggests that high-throughput methods
`may be devised to detect protein-protein interaction;
`by FRET on a genomewide basis (1) (Fig. 3A) . In such
`scheme, an appropriate host (yeast or bacteria) waul
`be transformed with a vector containing a given co.ding
`sequence (or a library) fused with CFP and a second
`vector with a library fused to YFP and then grown on
`selective media. Only a small fraction of the surviving
`clones are expected to have an altered fluorescena
`emission ratio, indicative of a protein-protein interac
`tion; the major task would then be to identify an
`isolate these positive clones for further analysis . Fortu(cid:173)
`nately, existing technologies can be adapted for such
`task: isolation of positive clones from liquid cultures
`can be performed by iterative cycles of fluorescence(cid:173)
`activated cell sorting (FACS), as was previously don
`for the identification of strongly fluorescent variants~
`GFP (9). Solid-phase screening directly from agar plate!
`containing the transformants is also possible: digi
`imaging spectroscopy (DIS) can record spectral informs
`tion from any two-dimensional surface in a massiveJ
`parallel fashion (39). Thus DIS could be configured
`report the CFP-to-YFP emission ratio of every pixel in
`given field, allowing simultaneous imaging of up to 21
`agar plates in certain setups. Using either FACS or
`DIS, positive clones could be expanded, and the protein
`protein interactions giving rise to changes in emissiot
`ratio could be characterized.
`Whereas FRET is ideally suited to detect heterotyp"
`protein interactions, proximity imaging (PRIM) is
`novel technique that can optically report homotyp
`interactions of GFP-labeled proteins (12). PRIM e~
`ploys the original wild-type GFP with two amino a
`
`h ttp://physiolgenomics. physiology.org
`
`7
`
`

`

`A
`
`B
`
`X
`
`X
`
`X
`
`REVIEW
`
`97
`
`Fig. 3. Analysis of protein-protein interactions with
`green fluorescent protein (GFP)-based probes . A: detec(cid:173)
`tion of heterotypic protein interaction with F RET be(cid:173)
`tween cyan fluorescent protein (CFP) fusion to protein X
`and yellow fluorescent protein (YFP) to protein Y. Under
`optimal proXimity and angular conditions, interaction
`between X andY (rig ht ) causes a decrease in intensity of
`CFP fluorescence concomitant with an increase in inten(cid:173)
`sity of YFP fluorescence. B: detection of homotypic
`protein interaction of protein X using proximity imaging
`(PRIM) with thermotolerant GFP (tt GFP). Under opti(cid:173)
`mal proximity and angular conditions, self-associa tion
`of X will produce a change in exci tation ratio of ttGFP
`(depicted by change in shape of shading within ttGFP
`rectangle).
`
`tt
`GFP
`
`I I
`
`X
`
`tt
`GFP
`~ I
`X
`
`substitutions that help the protein fold at 37°C (32)
`[henceforth referred to as ttGFP (thermotolerant GFP)].
`Unlike the GFP variants with simplified excitation
`spectra used in FRET, ttGFP possesses two excitation
`peaks (at 395 and 475 nm) and one emission peak (at
`510 nm). The ratio of intensities ofthe excitation peaks,
`i.e. , the excitation ratio, is the same for any ttGFP(cid:173)
`labeled protein that is monomeric. However, on dimer(cid:173)
`ization, deviations from this excitation ratio occur (Fig.
`3B), detectable in vitro and in vivo (12, 24) . Unlike
`FRET, which is a quantum mechanical interaction
`between any D-A pair, PRIM is GFP specific and results
`from orientation-dependent structural interactions be(cid:173)
`tween two ttGFP modules that affect their excitation
`ratio. High-throughput identification of proteins or
`protein domains capable of self-association could be
`achieved by adapting FACS or DIS for excitation ratio
`imaging. Exhaustive screening for homotypic interac(cid:173)
`tions by PRIM would be unidimensional, requiring the
`expression of a single library of coding sequences fused
`to ttGFP. By comparison, exhaustive screening for
`pairwise heterotypic interactions (with any of the meth(cid:173)
`ods mentioned above) is a two-dimensional combinato(cid:173)
`rial process in which each coding sequence has to be
`tested against every other coding sequence, necessitat(cid:173)
`ing the expression of two libraries. A genome of 50,000
`coding sequences thus would minimally require the
`screening of 50,000 clones for homotypic interactions
`and 0. 5 X (50,000)2 or 1,250,000,000 clones for hetero(cid:173)
`tYPic interactions.
`Each of the above-mentioned techniques suffers from
`shortcomings in certain respects . Phage display tech(cid:173)
`niques are limited to the study of relatively small- to
`medium-size proteins lacking eukaryotic posttransla(cid:173)
`tional modifications (4). The yeast two-hybrid system is
`known to generate a high number of false positives clue
`to nonspecifically interacting proteins and transcrip(cid:173)
`tional autoactivation by the DNA-binding fusion pro-
`
`tein (2). Moreover, interactions have to take place
`within the yeast nucleus. In contrast , GFP-based FRET
`or PRIM measurements can be performed in bacteria,
`yeast, or other cell types; moreover, interactions can
`theoretically be detected within any subcellular organ(cid:173)
`elle. However, GFP-based measurements are ham(cid:173)
`pered by several problems. 1) The GFP mutants used as
`FRET donors typically photobleach at much faster
`rates than acceptors, complicating the analysis some(cid:173)
`what (26); with PRIM care must be taken not to
`illuminate samples too intensely in the UV range
`because this can cause excitation ratio changes through
`a photoisomerization effect (11). 2) A large number of
`labeled molecules have to be expressed to be detectable,
`preferably at similar levels in the case of FRET with
`CFP- and YFP-tagged proteins; the detection threshold
`
`A
`
`8
`
`Fig. 4. Ana lysis of regulatory regions using [3-lactamase cleavage of
`CCF2 . A: CCF2 consists of blue-emitting coumarin (donor D) linked
`to green-emitting fluorescein (acceptor A) via a [3-lactam bond. In
`cells lacking [3-lactamase, excitation of D results in fluorescence
`emission predominantly from A due to FRET in the intact probe. B: in
`presence of [3-lactamase (scissors), CCF2 is cleaved, disrupting
`FRET; excitation ofD res ults in emission predominantly from D.
`
`http://physiolgenomics.physiology.org
`
`8
`
`

`

`98
`
`REVIEW
`
`is 200 nM or - 2,000 copies/cell for yeast and 200
`copies/cell for E. coli (28). This can pose certain prob(cid:173)
`lems, for instance in cases where a protein is toxic to
`the host above a certain threshold concentration. 3)
`Stringent distance and angular requirements for FRET
`and PRIM signals might contribute to a large number
`of false negatives, i.e., proteins that actually interact
`but do not produce a change. in the emission ratio
`(FRET) or excitation ratio (PRIM) because of unfavor(cid:173)
`able geometry of the GFP modules within the protein
`complex. Despite these shortcomings, screening protein(cid:173)
`protein interactions using GFP-based techniques can
`be a valid alternative, especially when screening for
`homotypic protein interactions or when eukaryotic
`posttranslational modifications or specific subcellular
`localization of the target proteins is required.
`
`ANALYSIS OF REGULATORY SEQUENCES WITH FRET
`
`Functional genomics would be incomplete without an
`understanding of the way in which regulatory se(cid:173)
`quences dynamically con

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket